Current Report Filing (8-k)
April 03 2017 - 4:06PM
Edgar (US Regulatory)
United States
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported): March 29, 2017
CHINA JO-JO DRUGSTORES, INC.
(Exact name of Registrant as specified
in charter)
Nevada
|
|
001-34711
|
|
98-0557852
|
(State or other jurisdiction of Incorporation)
|
|
(Commission File No.)
|
|
(IRS Employer Identification No.)
|
1st Floor, Yuzheng Plaza, No. 76, Yuhuangshan Road
Hangzhou, Zhejiang Province, People’s
Republic of China
(Address of principal executive offices)
(Zip Code)
Registrant's telephone number, including
area code:
+86 (571) 88077078
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant
to Rule 425 under the Securities Act (17CFR230.425)
☐ Soliciting material pursuant
to Rule14a-12 under the Exchange Act (17CFR240.14a-12)
☐ Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17CFR240.14d-2(b))
☐ Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17CFR240.13e-4(c))
Item 5.07 Submission of Matters
to a Vote of Security Holders.
On March 29, 2017, the registrant held
its annual meeting of shareholders for its fiscal year ended March 31, 2016. A quorum was present at the meeting as required by
the Bylaws of the Company, as amended. The final voting results for each matter submitted to a vote of shareholders at the meeting
are as follows. No broker non-votes were counted for any of the proposals as the Company chose to.
1.
|
A proposal to elect five directors to the registrant’s board of directors to hold office until the next
annual meeting and until their successors are duly elected and qualified:
|
Director’s Name
|
|
|
Votes For
|
|
|
|
Votes Against
|
|
Lei Liu
|
|
|
16,954,534
|
|
|
|
11,912
|
|
Li Qi
|
|
|
16,956,534
|
|
|
|
9,912
|
|
Caroline Wang
|
|
|
16,586,033
|
|
|
|
380,413
|
|
Taihong Guo
|
|
|
16,846,334
|
|
|
|
120,112
|
|
Genghua Gu
|
|
|
16,846,833
|
|
|
|
119,613
|
|
2.
|
A proposal to amend the Company’s 2010 Equity Incentive Plan to increase by 2,521,468 shares that are
available for issuance thereunder:
|
For
|
|
|
Against
|
|
|
Abstain
|
|
|
16,439,079
|
|
|
|
525,618
|
|
|
|
1,749
|
|
3.
|
A proposal to ratify the appointment of BDO CHINA SHU LUN PAN Certified Public Accountants LLP as the Company's
independent registered public accounting firm for the fiscal year ending March 31, 2017:
|
For
|
|
|
Against
|
|
|
Abstain
|
|
|
16,964,646
|
|
|
|
1,800
|
|
|
|
-
|
|
Pursuant to the foregoing votes, Lei
Liu, Li Qi, Caroline Wang, Taihong Guo, and Genghua Gu were elected to serve as directors; the Company’s 2010 Equity Incentive
Plan was amended to increase by 2,521,468 shares that are available for issuance thereunder; BDO CHINA SHU LUN PAN Certified Public
Accountants LLP was ratified as the registrant’s independent registered public accounting firm for the fiscal year ending
March 31, 2017.
2
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
CHINA JO-JO DRUGSTORES, INC.
|
|
|
Date: April 3, 2017
|
By:
|
/s/ Lei Liu
|
|
Name:
Title:
|
Lei Liu
Chief Executive
Officer
|
China Jo Jo Drugstores (NASDAQ:CJJD)
Historical Stock Chart
From Mar 2024 to Apr 2024
China Jo Jo Drugstores (NASDAQ:CJJD)
Historical Stock Chart
From Apr 2023 to Apr 2024